Population | Women with chronic kidney disease (as defined by eGFR or presence of kidney damage) |
---|---|
Population | Women with chronic kidney disease (as defined by eGFR or presence of kidney damage) |
Exposure | Hormone Therapy (HT) (all types of HT including estradiol alone or estradiol and progesterone) |
Comparator | Placebo or No HT |
Outcome | All-cause and cardiovascular mortality |
Design | RCTs, cohort, and case–control studies |